Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC

20 mg/m2, 75 mg/m2 infusion

AUC of 2 and 6 infusion

NEOADJUVANT RADIOTHERAPY Radiation therapy will be concurrent with the chemotherapy. Radiation therapy will begin within 24 hours of chemotherapy. CONSOLIDATION RADIOTHERAPY Patients with positive surgical margins or incomplete resection (tumor shaved from spine or great vessels) will receive an additional boost of radiotherapy 3 to 6 weeks after surgery. This will be a 16 Gy boost given with concurrent weekly chemotherapy as during the neoadjuvant period.

All patients will be taken to surgical excision, unless they have developed a condition other than progressive disease, which would make surgery unsafe.